ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like FDA Calls Roche's Leukemia Drug a Breakthrough July 27, 2017 Bay Area's XOMA Snags $240M Deal With Newly-Transformed Rezolute December 6, 2017 Bionik Laboratories Corp. Issues Letter To Shareholders August 21, 2017
